-
Mayne Pharma International Pty Ltd. v. Prinston Pharmaceutical Inc. DC
- 1:19-cv-00549
- D. Del.
- Judge: Richard G. Andrews
- Filed: 03/21/2019
- Closed: 09/16/2019
- Latest Docket Entry: 09/16/2019
- PACER
1
Plaintiff
3
Defendants
1
Accused
Product
3
Patents-in-Suit
180
Days in
Litigation
-
Mayne Pharma International Pty Ltd. v. Prinston Pharmaceutical Inc. DC
- 1:19-cv-00549
- D. Del.
- Judge: Richard G. Andrews
- Filed: 03/21/2019
- Closed: 09/16/2019
- Latest Docket Entry: 09/16/2019
- PACER
Causes of Action
Infringement
Declaratory Judgment
Patent Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
Patent Information
-
Validity & Enforceability
-
Infringement
Prinston Pharmaceutical Incorporated
- 3 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
120 mg doxycycline hyclate | US 9,295,652 B1 | All Asserted Claims |
Infringement
Entry 18
|
120 mg doxycycline hyclate | US 9,446,057 B2 | All Asserted Claims |
Infringement
Entry 18
|
120 mg doxycycline hyclate | US 9,511,031 B2 | All Asserted Claims |
Infringement
Entry 18
|